The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Sertraline for the Treatment of Depression in Alzheimer Disease
Open accessAbstract
Objective Depression is common in Alzheimer disease (AD), and antidepressants are commonly used for its treatment, however, evidence for antidepressant efficacy in this population is lacking. The authors conducted a multicenter, randomized, placebo-controlled trial titled "Depression in Alzheimer's Disease-2" to assess the efficacy and tolerability of sertraline for depression in AD.Methods One hundred thirty-one participants from five U.S. medical centers with mild-to-moderate AD (Mini-Mental State Examination scores 10-26) and depression of AD were randomized to double-blinded treatment with sertraline (N = 67) or placebo (N = 64), with a target dosage of 100 mg daily. Efficacy was assessed using logistic regressions and mixed effects models in an intention-to-treat analysis with imputation of missing data. Principal outcome measures were modified Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change (mADCS-CGIC), change in Cornell Scale for Depression in Dementia (CSDD) scores, and remission defined by both mADCS-CGIC score <or=2 and CSDD score <or=6.Results mADCS-CGIC ratings (odd ratio [OR = 1.01], 95% confidence interval [CI]: 0.52-1.97, p = 0.98), CSDD scores (median difference at 12 weeks 1.2, 95% CI: 1.65-4.05, p = 0.41), and remission at 12 weeks of follow-up (OR = 2.06, 95% CI: 0.84-5.04, p = 0.11) did not differ between sertraline (N = 67) and placebo (N = 64). Sertraline-treated patients experienced more adverse events, most notably gastrointestinal and respiratory, than placebo-treated patients.Conclusion Sertraline did not demonstrate efficacy for the treatment depression symptoms in patients with AD. In addition, its use was associated with an increased incidence of adverse events. Thus, selective serotonin reuptake inhibitors may be of limited value for treating depression in patients with AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“(b) antidepressant medication causes severe neurological side effects, which reflect antidepressants interfering with brain function, possibly via altering neurotransmitter systems [29-31]”
From Risk analysis of use of different classes of antidepressants on subsequent dementia: A nationwide cohort study in Taiwan (2017) · cites this paper as [30]
Experimental — accuracy not yet measuredIn the citing paper
“While this method of drug discovery has the attractive feature of studying drugs with generally well-characterized safety profiles, it is inherently limited especially in terms of interpreting null results (Rosenberg et al., 2010).”
From Neuropsychiatric symptoms in Alzheimer's disease: what might be associated brain circuits? (2015) · cites this paper as Rosenberg et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Multiple imputation after 18+ years
Rubin, D. B. (1996) · Journal of the American Statistical Association · doi:10.1080/01621459.1996.10476908 · Cited by 4,072
Multiple Imputation After 18+ Years
Rubin, D. B. (1996) · Journal of the American Statistical Association · doi:10.2307/2291635 · Cited by 2,686
Cornell scale for depression in dementia
Alexopoulos, G. S., Abrams, R. C., Young, R. C., & Shamoian, C. A. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90038-8 · Cited by 2,678
Point and 5‐year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study
Steinberg, M., Shao, H., Zandi, P., Lyketsos, C. G., Welsh‐Bohmer, K. A., Norton, M. C., Breitner, J. C. S., Steffens, D. C., & Tschanz, J. T. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1858 · Cited by 780
Self-citationMultiple Imputation for Nonresponse in Surveys
Campion, W. M., & Rubin, D. B. (1989) · Journal of Marketing Research · doi:10.2307/3172772 · Cited by 775
Exercise Plus Behavioral Management in Patients With Alzheimer Disease
Teri, L. L., Gibbons, L. E., McCurry, S. M., Logsdon, R. G., Büchner, D. M., Barlow, W. E., Kukull, W. A., LaCroix, A. Z., McCormick, W. C., & Larson, E. B. (2003) · JAMA · doi:10.1001/jama.290.15.2015 · Cited by 765
Schneider, L., Olin, J. T., Doody, R. S., Clark, C. M., Morris, J. C., Reisberg, ., Schmitt, F. A., Grundman, M., Thomas, R. G., & Ferris, S. H. (1997) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199700112-00004 · Cited by 646
Self-citationProvisional Diagnostic Criteria for Depression of Alzheimer Disease
Olin, J. T., Schneider, L. S. S., Katz, I. R., Meyers, B. S., Alexopoulos, G. S., Breitner, J. C. S., BRUCE, M. L., Caine, E. D., Cummings, J. L., Devanand, D. P., et al. (2002) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200203000-00003 · Cited by 426
Self-citationLyketsos, C. G., DelCampo, L., Steinberg, M., Miles, Q., Steele, C. D., Munro, C., Baker, A. S., Sheppard, J.-M. E., Frangakis, C., Brandt, J., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.737 · Cited by 398
Self-citationDepression in Alzheimer’s disease: overview and treatment
Lyketsos, C. G., & Olin, J. T. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01348-3 · Cited by 393
Self-citationNyth, A. L., & Gottfries, C. G. (1990) · British Journal of Psychiatry · doi:10.1192/bjp.157.6.894 · Cited by 379
Double-blind trial of imipramine in Alzheimer's disease patients with and without depression
Reifler, B. V., Teri, L. L., Raskind, M. A., Veith, R. C., Barnes, R., White, E., & McLean, P. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.1.45 · Cited by 342
Provisional Diagnostic Criteria for Depression of Alzheimer Disease: Rationale and Background
Olin, J. T., Katz, I. R., Meyers, B. S., Schneider, L. S. S., & Lebowitz, B. D. (2002) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200203000-00004 · Cited by 321
Self-citationProvisional Diagnostic Criteria for Depression of Alzheimer Disease
Olin, J. T. (2002) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.10.2.125 · Cited by 313
Schneider, L. S. S., Olin, J. T., Doody, R. S., Clark, C. M., Morris, J. C., Reisberg, ., Ferris, S. H., Schmitt, F. A., Grundman, M., & Thomas, R. G. (1997) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-4116-4_64 · Cited by 300
Self-citationLyketsos, C. G., Sheppard, J. E., Steinberg, M., Tschanz, J. A. T., Norton, M. C., Steffens, D. C., & Breitner, J. C. S. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.448 · Cited by 275
Self-citationDeterminants of costs of care for patients with Alzheimer's disease
Jönsson, L., Eriksdotter, M., Kilander, L., Soininen, H. S., Hallikainen, M., Waldemar, G., Nygaard, H. A., Andreasen, N., Winblad, B. G., & Wimo, A. B. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1489 · Cited by 225
Lyketsos, C. G., Leoutsakos, J., Steele, C. D., Kopunek, S., Steinberg, M., Baker, A. S., Brandt, J., & Rabins, P. V. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1686 · Cited by 214
Self-citationRoth, M., Mountjoy, C. Q., Amrein, R., & The International Collaborative Study Group (1996) · The British Journal of Psychiatry · doi:10.1192/bjp.168.2.149 · Cited by 186
Petracca, G., Tesón, A., Chemerinski, E., Leiguarda, R. C., & STARKSTEIN, S. E. (1996) · Journal of Neuropsychiatry · doi:10.1176/jnp.8.3.270 · Cited by 174
Teri, L. (1997) · PubMed · Cited by 173
The persistence of neuropsychiatric symptoms in dementia: the Cache County Study
Steinberg, M., Tschanz, J. T., Corcoran, C. D., Steffens, D. C., Norton, M. C., Lyketsos, C. G., & Breitner, J. C. S. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1025 · Cited by 164
Self-citationMace, N. L., & Rabins, P. V. (1999) · Medical Entomology and Zoology · Cited by 160
Self-citationPetracca, G., Chemerinski, E., & STARKSTEIN, S. E. (2001) · International Psychogeriatrics · doi:10.1017/s104161020100761x · Cited by 148
Rabins, P. V., Lyketsos, C. G., & Steele, C. D. (2006) · Oxford University Press eBooks · doi:10.1093/med/9780195169782.001.0001 · Cited by 146
Self-citationMagai, C., Kennedy, G., Cohen, C. I., & Gomberg, D. (2000) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200002000-00009 · Cited by 143
Research Consent for Cognitively Impaired Adults
Alzheimer's Association (2004) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000137520.23370.56 · Cited by 96
Provisional Diagnostic Criteria for Depression of Alzheimer Disease: Rationale and Background
Olin, J. T. (2002) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.10.2.129 · Cited by 72
Evolution of Depressive Symptoms in Alzheimer Disease
Garre‐Olmo, J., Pousa, S. L., Franch, J. V., Estrada, A. T., Hernández-Ferràndiz, M., Gallego, M. L., Tibau, C. F., Puig-Vidal, O., Muñoz, V. M., & Cruz-Reina, M. M. (2003) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200304000-00005 · Cited by 55
Devi, G. (2000) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.12.3.411 · Cited by 47
Clinical application of operationalized criteria for ‘Depression of Alzheimer's Disease’
Rosenberg, P. B., Onyike, C. U., Katz, I. R., Porsteinsson, A. P., Mintzer, J. E., Schneider, L. S. S., Rabins, P. V., Meinert, C. L., Martin, B. K., & Lyketsos, C. G. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1261 · Cited by 37
Self-citationDesign of Depression in Alzheimer's Disease Study-2
Martin, B. K., Frangakis, C., Rosenberg, P. B., Mintzer, J. E., Katz, I. R., Porsteinsson, A. P., Schneider, L. S. S., Rabins, P. V., Munro, C. A., Meinert, C. L., et al. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000240977.71305.ee · Cited by 37
Self-citationTreatment with antidepressants in patients with dementia – a nationwide register-based study
Kessing, L. V., Harhoff, M., & Andersen, P. K. (2006) · International Psychogeriatrics · doi:10.1017/s1041610206004376 · Cited by 33
Garre‐Olmo, J., Pousa, S. L., Franch, J. V., Estrada, A. T., Hernández-Ferràndiz, M., Gallego, M. L., Tibau, C. F., Puig-Vidal, O., Muñoz, V. M., & Cruz-Reina, M. M. (2002) · Revista de Neurología · doi:10.33588/rn.3407.2001415 · Cited by 20
Devi, G. (2000) · Journal of Neuropsychiatry · doi:10.1176/jnp.12.3.411 · Cited by 15
Neumonía eosinófila aguda secundaria a la administración de sertralina
Haro, M. L., Rubio, M., Xifré, B., & Castro, P. (2002) · Medicina Clínica · doi:10.1016/s0025-7753(02)73522-7 · Cited by 14
Research works printed but not linked: 1
- Garre-Olmo, 2002, Carer's burden and depressive symptoms in patients with Alzheimer's disease. State after twelve months, Rev Neurol, 34, 601
Cited by
Sorted by citations
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Self-citationMasters, C. L., Bateman, R., Blennow, K., Rowe, C. C., Sperling, R. A., & Cummings, J. L. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.56 · Cited by 1,853
Depression and risk of developing dementia
Byers, A. L., & Yaffe, K. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.60 · Cited by 1,265
Assessment and management of behavioral and psychological symptoms of dementia
Kales, H. C., Gitlin, L. N., & Lyketsos, C. G. (2015) · BMJ · doi:10.1136/bmj.h369 · Cited by 1,247
Self-citationNeuropsychiatric symptoms in Alzheimer's disease
Lyketsos, C. G., Carrillo, M. C., Ryan, J. M., Khachaturian, A. S., Trzepacz, P., Amatniek, J., Cedarbaum, J., Brashear, R., & Miller, D. S. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.05.2410 · Cited by 1,139
Self-citation
Metadata
- Authors
- Rosenberg, P. B., Martin, B. K., Frangakis, C., Mintzer, J. E., Weintraub, D., Porsteinsson, A. P., Schneider, L. S., Rabins, P. V., Munro, C. A., Meinert, C. L., Lyketsos, C. G., & Drye, L. T.
- Affiliations
- Johns Hopkins University (US)
- Medical University of South Carolina (US)
- Mental Illness Research, Education and Clinical Centers (US)
- University of Rochester Medicine (US)
- University of Southern California (US)
- Corresponding author
- Rosenberg, Paul B.
- ORCID
- Venue
- The American Journal of Geriatric Psychiatry
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 18
- Issue
- 2
- Pages
- 136-145
- ISSN
- 1064-7481 (ISSN-L)
- PMC
- PMC2842121
- OpenAlex
- W1983522355
- Cited by
- 250
- References
- 36
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 14 · 2023: 5 · 2022: 14 · 2021: 8 · 2020: 9 · 2019: 14 · 2018: 13 · 2017: 14 · 2016: 11 · 2015: 21 · 2014: 21 · 2013: 24 · 2012: 24
- FWCI
- 19.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Geriatric Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5u01mh068014-05, 5u01mh066176-05, 5u01mh066174-05, 5u01mh066177-05, 5u01mh066175-05)
- National Institute on Aging (K08AG029157, P50AG005142, P50AG005146)
- National Institute of Mental Health (U01 MH068014, U01 MH066174, 1U01MH066175, 1U01MH068014, U01MH066177, 1U01MH066177, 1U01MH066176, U01 MH066175, 1U01MH066174, U01 MH066176, U01MH066136)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- sertraline, Alzheimer's disease, depression, selective serotonin reuptake inhibitors, antidepressant efficacy, adverse events, depression remission, Cornell Scale for Depression in Dementia, mild to moderate dementia
- MeSH terms
- Assessment of Medication Adherence, Aged, Alzheimer Disease, Depression, Double-Blind Method, Female, Humans, Male, Patient Dropouts, Placebos, Treatment Outcome, Drug Monitoring, Selective Serotonin Reuptake Inhibitors, Sertraline, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
